Scoring System for Patients with Cancer to Weigh Risk/Benefit of Chemotherapy During Outbreak of COVID-19

Author Info

Reyad Dada Bassim T. Malas Al-Beirouti

Corresponding Author

Reyad Dada
King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia

A B S T R A C T

Coronavirus disease 2019 (COVID-19) is impacting our daily practice. Hematologist and oncologist around the globe are concerned and many physicians are hesitating to start/continue antineoplastic treatment in patients with cancer to protect them from severe complications in case of infection with the new novel corona virus. Therefore, we feel there is a high demand for scoring system to guide and help physicians dealing with patients with malignant diseases to take the correct decision. We have designed a scoring system to evaluate patients with cancer requiring anti-cancer treatment and we have started to implement it at our hospital. Therefore, we would like to share this scoring system with the community.

Article Info

Article Type

Research Article

Publication history

Received: Fri 10, Jul 2020
Accepted: Mon 20, Jul 2020
Published: Thu 20, Aug 2020

Copyright

© 2023 Reyad Dada. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.JCMCR.2020.02.07